No earnings within 2 weeks of this transaction.
| Insider | Wang Xiaolin |
|---|---|
| Title | EVP, Clinical Development |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 2,010 |
| Price per Share | $99.48 |
| Total Value | $199,955.60 |
| Shares Owned After | 116,063 |
| Derivative | No |
| Accession Number | 0001610717-26-000126 |
| Document | View SEC Filing |